Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anupma Nayak

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Annals of Diagnostic Pathology|March 23, 2011
Utility of cytokeratin 5/6 and high-molecular-weight keratin in evaluation of cauterized surgical margins in excised specimens of breast ductal carcinoma in situAnupma Nayak, Tawfiqul A Bhuiya
Seminars in Diagnostic Pathology|October 2, 2017
Iatrogenically false positive sentinel lymph nodes in breast cancer: Methods of recognition and evaluationAnupma Nayak, Ira J Bleiweiss
The Breast Journal|May 9, 2020
Iatrogenic issues in breast pathologyIra J Bleiweiss, Anupma Nayak
The American Journal of Surgical Pathology|May 1, 2013
Primary squamous cell carcinoma of the breast: predictors of locoregional recurrence and overall survivalAnupma Nayak, Yun Wu, Michael Z Gilcrease
Histopathology|August 19, 2014
Are cytokeratin-positive cells in sentinel lymph nodes of patients with invasive breast carcinomas up to 5 mm usually insignificant?Shabnam Jaffer, Ira J Bleiweiss, Anupma Nayak
Clinical Breast Cancer|April 24, 2017
The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 CasesXiaofei Zhang, Ira Bleiweiss, Shabnam Jaffer, et al.
Archives of Pathology & Laboratory Medicine|June 23, 2018
Not All Ductal Carcinomas In Situ Are Created IDLE (Indolent Lesions of Epithelial Origin)Melissa Alexander, Jessica Beyda, Anupma Nayak, et al.
The Journal of Surgical Research|December 17, 2021
PTGES3 is a Putative Prognostic Marker in Breast CancerAdeseye Adekeye, Divyansh Agarwal, Anupma Nayak, et al.
Archives of Pathology & Laboratory Medicine|September 8, 2018
Evaluation of Biomarkers in Multiple Ipsilateral Synchronous Invasive Breast CarcinomasPooja Navale, Ira J Bleiweiss, Shabnam Jaffer, et al.
Breast Cancer Research and Treatment|September 12, 2015
The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patientsXiaofei Zhang, Shabnam Jaffer, Ira J Bleiweiss, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Annals of Diagnostic Pathology|March 23, 2011
Utility of cytokeratin 5/6 and high-molecular-weight keratin in evaluation of cauterized surgical margins in excised specimens of breast ductal carcinoma in situAnupma Nayak, Tawfiqul A Bhuiya
Seminars in Diagnostic Pathology|October 2, 2017
Iatrogenically false positive sentinel lymph nodes in breast cancer: Methods of recognition and evaluationAnupma Nayak, Ira J Bleiweiss
The Breast Journal|May 9, 2020
Iatrogenic issues in breast pathologyIra J Bleiweiss, Anupma Nayak
The American Journal of Surgical Pathology|May 1, 2013
Primary squamous cell carcinoma of the breast: predictors of locoregional recurrence and overall survivalAnupma Nayak, Yun Wu, Michael Z Gilcrease
Histopathology|August 19, 2014
Are cytokeratin-positive cells in sentinel lymph nodes of patients with invasive breast carcinomas up to 5 mm usually insignificant?Shabnam Jaffer, Ira J Bleiweiss, Anupma Nayak
Clinical Breast Cancer|April 24, 2017
The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 CasesXiaofei Zhang, Ira Bleiweiss, Shabnam Jaffer, et al.
Archives of Pathology & Laboratory Medicine|June 23, 2018
Not All Ductal Carcinomas In Situ Are Created IDLE (Indolent Lesions of Epithelial Origin)Melissa Alexander, Jessica Beyda, Anupma Nayak, et al.
The Journal of Surgical Research|December 17, 2021
PTGES3 is a Putative Prognostic Marker in Breast CancerAdeseye Adekeye, Divyansh Agarwal, Anupma Nayak, et al.
Archives of Pathology & Laboratory Medicine|September 8, 2018
Evaluation of Biomarkers in Multiple Ipsilateral Synchronous Invasive Breast CarcinomasPooja Navale, Ira J Bleiweiss, Shabnam Jaffer, et al.
Breast Cancer Research and Treatment|September 12, 2015
The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patientsXiaofei Zhang, Shabnam Jaffer, Ira J Bleiweiss, et al.
Pageof 7